Current Psychopharmacology

Review Article

The Present Difficulties and Potential Benefits of Dopaminergic Agents in Parkinson's Disease Treatment

Article ID: e22115560332182
Author(s): Shivendra Kumar*, Harsh Bharadwaj, Sunam Saha, Kuldeep Singh, Parshant Kumar, Swamita Arora, Deep Chandra*, Deepali Vij, Shilpa Srivastava, Kapil Gupta and Ashish Srivastava
DOI: 10.2174/0122115560332182241031050521
Published on: 12 November, 2024

Cite

Case Report

Positive Psychotic Symptoms after Escitalopram Treatment in a Female Adolescent with Peroxisome Spectrum Disorder Due to PEX-6 Gene Mutation

Article ID: e22115560310023
Author(s): Buket Kılıç* and Dilek Ünal
DOI: 10.2174/0122115560310023240823103145
Published on: 06 September, 2024

Cite

Review Article

A Literature-Based Study of Tardive Dyskinesia- From Pathogenesis to Treatment

Article ID: e22115560304943
Author(s): Banjit Kalita, Tapash Chakraborty*, Shatabdi Ghose and Bhaskarjyoti Kalita
DOI: 10.2174/0122115560304943240822052622
Published on: 03 September, 2024

Cite

Review Article

Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence

Article ID: e030724231519
Author(s): Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla and Samer El Hayek*
DOI: 10.2174/0122115560288779240628043307
Published on: 03 July, 2024

Cite

Case Report

Rapid Metabolism of Monthly Extended-Release Buprenorphine Formulation: A Case Report

Article ID: e310524230588
Author(s): Hossameldin Tolba, Wael Foad and Samer El Hayek*
DOI: 10.2174/0122115560292967240527072922
Published on: 31 May, 2024

Cite

Research Article

Hippocampal Serotonin and Responses to Immobilization Stress in Rats Treated with Metformin

Article ID: e290424229519
Author(s): Rushda Afroz*, Tabinda Salman, Shazia Nawaz, Nazish Mustafa, Munnum Zafar and Darakhshan Jabeen Haleem
DOI: 10.2174/0122115560289942240427041345
Published on: 29 April, 2024

Cite

Editorial

Have We Placed the Cart Before the Horse by Using Alpha-_2A Agonists to Treat Rejection Sensitivity Dysphoria in ADHD?

Article ID: e050424228696
Author(s): William W. Dodson and Edward Justin Modestino*
DOI: 10.2174/0122115560297397240404071044
Published on: 05 April, 2024

Cite

Mini-Review Article

Semaglutide’s Neuropharmacological Effects: From Glycemic Regulation and Weight Loss to Potential Implications in Substance Use Disorders – A Narrative Review

Article ID: e301223225100
Author(s): Jes Sebastian Denis Völker*, Ioana Valentina Micluția and Ramona-Cristina Vinași
DOI: 10.2174/0122115560282952231218061257
Published on: 30 December, 2023

Cite

Review Article

The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders

Article ID: e190124225864
Author(s): Indu Arora, Kunal Khurana and Manish Kumar*
DOI: 10.2174/0122115560281804240102054639
Published on: 19 January, 2024

Cite

Review Article

The Neurochemical Anatomy of Runway Acquisition and Extinction

Article ID: e301223225099
Author(s): Robert Lalonde* and Catherine Strazielle
DOI: 10.2174/0122115560268626231214070304
Published on: 30 December, 2023

Cite

Review Article

A Comprehensive Review on the Neuropharmacological Effects of Antidepressants in Various Prospects

Article ID: e070723218522
Author(s): Sandesh Varshney, Md. Aftab Alam*, Awaneet Kaur* and Shaweta Sharma*
DOI: 10.2174/2211556011666230707122341
Published on: 13 July, 2023

Cite

Current Psychopharmacology

Submission for General Articles

Submit to Thematic Issues

Call for Conference Speakers

Special Open Access APC Discount

Volume 12